762 related articles for article (PubMed ID: 33060566)
21. Pathologic features of COVID-19: A concise review.
Tabary M; Khanmohammadi S; Araghi F; Dadkhahfar S; Tavangar SM
Pathol Res Pract; 2020 Sep; 216(9):153097. PubMed ID: 32825963
[TBL] [Abstract][Full Text] [Related]
22. Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase.
Cross RW; Agans KN; Prasad AN; Borisevich V; Woolsey C; Deer DJ; Dobias NS; Geisbert JB; Fenton KA; Geisbert TW
Virol J; 2020 Aug; 17(1):125. PubMed ID: 32811514
[TBL] [Abstract][Full Text] [Related]
23. Clinical, Serological, and Histopathological Similarities Between Severe COVID-19 and Acute Exacerbation of Connective Tissue Disease-Associated Interstitial Lung Disease (CTD-ILD).
Gagiannis D; Steinestel J; Hackenbroch C; Schreiner B; Hannemann M; Bloch W; Umathum VG; Gebauer N; Rother C; Stahl M; Witte HM; Steinestel K
Front Immunol; 2020; 11():587517. PubMed ID: 33123171
[TBL] [Abstract][Full Text] [Related]
24. A proof of evidence supporting abnormal immunothrombosis in severe COVID-19: naked megakaryocyte nuclei increase in the bone marrow and lungs of critically ill patients.
Roncati L; Ligabue G; Nasillo V; Lusenti B; Gennari W; Fabbiani L; Malagoli C; Gallo G; Giovanella S; Lupi M; Salviato T; Paolini A; Costantini M; Trenti T; Maiorana A
Platelets; 2020 Nov; 31(8):1085-1089. PubMed ID: 32857624
[TBL] [Abstract][Full Text] [Related]
25. Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury.
Guo J; Wei X; Li Q; Li L; Yang Z; Shi Y; Qin Y; Zhang X; Wang X; Zhi X; Meng D
J Cell Physiol; 2020 Dec; 235(12):9884-9894. PubMed ID: 32510598
[TBL] [Abstract][Full Text] [Related]
26. SARS-CoV-2, More than a Respiratory Virus: Its Potential Role in Neuropathogenesis.
Singal CMS; Jaiswal P; Seth P
ACS Chem Neurosci; 2020 Jul; 11(13):1887-1899. PubMed ID: 32491829
[TBL] [Abstract][Full Text] [Related]
27. Early Insights into Immune Responses during COVID-19.
St John AL; Rathore APS
J Immunol; 2020 Aug; 205(3):555-564. PubMed ID: 32513850
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic and Immunohistochemical Findings from Autopsy of Patient with COVID-19, Japan.
Adachi T; Chong JM; Nakajima N; Sano M; Yamazaki J; Miyamoto I; Nishioka H; Akita H; Sato Y; Kataoka M; Katano H; Tobiume M; Sekizuka T; Itokawa K; Kuroda M; Suzuki T
Emerg Infect Dis; 2020 Sep; 26(9):2157-61. PubMed ID: 32412897
[TBL] [Abstract][Full Text] [Related]
29. COVID-19 as a STING disorder with delayed over-secretion of interferon-beta.
Berthelot JM; Lioté F
EBioMedicine; 2020 Jun; 56():102801. PubMed ID: 32454408
[No Abstract] [Full Text] [Related]
30. [How to understand the histopathology of SARS and coronavirus disease-19 (COVID-19) associated with acute respiratory distress syndrome].
Chen J
Zhonghua Bing Li Xue Za Zhi; 2020 Apr; 49(4):289-290. PubMed ID: 32157847
[TBL] [Abstract][Full Text] [Related]
31. Global Initiative Seeks to Crack the COVID-19 Genetic Code.
Am J Med Genet A; 2020 Sep; 182(9):1998-1999. PubMed ID: 32881367
[No Abstract] [Full Text] [Related]
32. Immune monitoring of interleukin-7 compassionate use in a critically ill COVID-19 patient.
Monneret G; de Marignan D; Coudereau R; Bernet C; Ader F; Frobert E; Gossez M; Viel S; Venet F; Wallet F
Cell Mol Immunol; 2020 Sep; 17(9):1001-1003. PubMed ID: 32728202
[No Abstract] [Full Text] [Related]
33. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients.
Dai YJ; Zhang WN; Wang WD; He SY; Liang CC; Wang DW
Int J Biol Sci; 2020; 16(15):3028-3036. PubMed ID: 33061814
[TBL] [Abstract][Full Text] [Related]
34. COVID-19: a conundrum to decipher.
Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
[TBL] [Abstract][Full Text] [Related]
35. A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice.
Leist SR; Dinnon KH; Schäfer A; Tse LV; Okuda K; Hou YJ; West A; Edwards CE; Sanders W; Fritch EJ; Gully KL; Scobey T; Brown AJ; Sheahan TP; Moorman NJ; Boucher RC; Gralinski LE; Montgomery SA; Baric RS
Cell; 2020 Nov; 183(4):1070-1085.e12. PubMed ID: 33031744
[TBL] [Abstract][Full Text] [Related]
36. Lung transcriptome of a COVID-19 patient and systems biology predictions suggest impaired surfactant production which may be druggable by surfactant therapy.
Islam ABMMK; Khan MA
Sci Rep; 2020 Nov; 10(1):19395. PubMed ID: 33173052
[TBL] [Abstract][Full Text] [Related]
37. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets.
Bojkova D; Klann K; Koch B; Widera M; Krause D; Ciesek S; Cinatl J; Münch C
Nature; 2020 Jul; 583(7816):469-472. PubMed ID: 32408336
[TBL] [Abstract][Full Text] [Related]
38. Serum Protein Profiling Reveals a Landscape of Inflammation and Immune Signaling in Early-stage COVID-19 Infection.
Hou X; Zhang X; Wu X; Lu M; Wang D; Xu M; Wang H; Liang T; Dai J; Duan H; Xu Y; Yu X; Li Y
Mol Cell Proteomics; 2020 Nov; 19(11):1749-1759. PubMed ID: 32788344
[TBL] [Abstract][Full Text] [Related]
39. A rampage through the body.
Wadman M; Couzin-Frankel J; Kaiser J; Matacic C
Science; 2020 Apr; 368(6489):356-360. PubMed ID: 32327580
[No Abstract] [Full Text] [Related]
40. In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19.
Schaefer IM; Padera RF; Solomon IH; Kanjilal S; Hammer MM; Hornick JL; Sholl LM
Mod Pathol; 2020 Nov; 33(11):2104-2114. PubMed ID: 32561849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
